AUS Edition 
NZ Edition 
UK Edition 
CA Edition 
USA Edition 
FRA Edition 
GER Edition 
ESP Edition 
ITA Edition 
NLD Edition 
PRT Edition 
SWE Edition 
GRC Edition 
IND Edition 
POL Edition 
BRA Edition 
ZAF Edition 
RUS Edition 
CHN Edition 
UAE Edition 
⚠
✓
Warby Parker Inc (NYSE:WRBY)
21.76 USD
+0.280 1.304%Sponsored Reports
Loading...
| Previous Close (in USD) | 21.48 |
|---|---|
| Change | +0.280 1.304% |
| 52 W H/L (in USD) | 17.880/9.500 |
| EBITDA (in USD) | -35.036M |
| PE Ratio | -- |
| Volume | 403911 |
| Diluted Eps TTM | -0.56 |
| Total Assets (in USD) | 568.707M |
|---|---|
| Total Liabilities (in USD) | 282.061M |
| Revenue TTM (in USD) | 654.403M |
| Cash (in USD) | 208.585M |
| Market Cap (in USD) | 1,617.550 M |
| Revenue Per Share TTM | 5.609 |
| Gross Profit TTM (in USD) | 341.062M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Warby Parker Inc
Warby Parker Inc. provides eyewear products. The company offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses. It also provides accessories, such as cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray through its retail stores, website, and mobile apps. In addition, the company offers eye exams and vision tests. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.
Employees: 1860
Key Executives
| Sr. No. | Name | Title | Year Born |
|---|---|---|---|
| 1. | Mr. Neil Harris Blumenthal | Co-Founder, Pres, Co-CEO & Co-Chair | 1981 |
| 2. | Mr. David Abraham Gilboa | Co-Founder, Co-CEO & Co-Chair | 1982 |
| 3. | Mr. Andrew M. Hunt | Co-Founder & Independent Director | NA |
| 4. | Mr. Jeff Raider | Co-Founder & Independent Director | NA |
| 5. | Mr. Steve Miller | Sr. VP & CFO | NA |
| 6. | Ms. Stephanie Pullings Hart | Sr. VP of Operations | 1974 |
| 7. | Mr. Jeffrey Saunders | Sr. VP & CTO | NA |
| 8. | Ms. Tina Romani | VP of Investor Relations | NA |
| 9. | Ms. Lori Krauss | Sr. VP & Chief Marketing Officer | NA |
| 10. | Ms. Chelsea Kaden | Sr. VP & Head of People | NA |
Peers
Sector: Healthcare
Industry: Medical Instruments & Supplies
| Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
|
ISRG
Intuitive Surgical Inc |
+8.585 1.607% | 536.87 | 73.050 | 61.728 | 19.145 | 10.247 | 18.408 | 59.920 |
|
ESLOY
Essilor International SA |
+1.850 1.367% | 136.85 | 35.390 | 24.814 | 3.630 | 2.204 | 3.996 | 16.255 |
|
ESLOF
EssilorLuxottica Société anonyme |
-0.250 0.091% | 275 | 35.710 | 25.126 | 3.623 | 2.229 | 3.995 | 16.251 |
|
BDX
Becton Dickinson and Company |
+1.780 1.047% | 170.545 | 37.720 | 15.924 | 3.252 | 2.490 | 4.085 | 17.104 |
Income Statement
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
|---|---|---|---|---|
| Income Before Tax | -109.896M | -144.008M | -55.729M | 0.276M |
| Minority Interest | - | - | - | - |
| Net Income | -110.393M | -144.271M | -55.919M | 0M |
| Selling General Administrative | 452.265M | 461.41M | 287.567M | 224.771M |
| Gross Profit | 341.062M | 317.749M | 231.935M | 223.108M |
| Reconciled Depreciation | 31.864M | 21.868M | 18.377M | 14.516M |
| Ebit | -111.203M | -143.661M | -55.632M | -1.663M |
| Ebitda | -79.339M | -121.793M | -37.255M | 12.853M |
| Depreciation And Amortization | 31.864M | 21.868M | 18.377M | 14.516M |
| Operating Income | -111.203M | -143.661M | -55.632M | -1.663M |
| Other Operating Expenses | 709.315M | 684.459M | 449.351M | 372.126M |
| Interest Expense | -1.307M | 0.347M | 0.097M | 1.939M |
| Tax Provision | 0.497M | 0.263M | 0.19M | 0.276M |
| Interest Income | - | - | - | - |
| Net Interest Income | 1.307M | -0.347M | -0.097M | 1.939M |
| Income Tax Expense | 0.497M | 0.263M | 0.19M | 0.276M |
| Total Revenue | 598.112M | 540.798M | 393.719M | 370.463M |
| Total Operating Expenses | 452.265M | 461.41M | 287.567M | 224.771M |
| Cost Of Revenue | 257.05M | 223.049M | 161.784M | 147.355M |
| Total Other Income Expense Net | 1.307M | -0.347M | -0.097M | 1.939M |
| Net Income From Continuing Ops | -110.393M | -144.271M | -55.919M | 0M |
| Net Income Applicable To Common Shares | -110.393M | -157.408M | -55.919M | -57.537M |
Balance Sheet
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
|---|---|---|---|---|
| Total Assets | 568.707M | 440.646M | 444.751M | 175.856M |
| Intangible Assets | - | - | - | - |
| Other Current Assets | 15.7M | 13.477M | 6.779M | 6.705M |
| Total Liab | 282.061M | 154.648M | 136.338M | 102.46M |
| Total Stockholder Equity | 286.646M | 285.998M | 308.413M | 73.396M |
| Other Current Liab | 60.592M | 4.301M | 3.722M | 2.958M |
| Common Stock | 0.012M | 0.011M | 0.005M | 0.005M |
| Capital Stock | 0.012M | 0.011M | 506.515M | 262.854M |
| Retained Earnings | -603.634M | -493.241M | -325.39M | -269.471M |
| Good Will | - | - | - | - |
| Other Assets | 8.497M | 0.471M | 0.284M | 0.282M |
| Cash | 208.585M | 256.416M | 314.085M | 55.424M |
| Cash And Equivalents | - | - | - | - |
| Total Current Liabilities | 129.557M | 118.104M | 105.33M | 75.867M |
| Current Deferred Revenue | 25.628M | 22.073M | 26.55M | 19.249M |
| Net Debt | -35.207M | -256.416M | -314.085M | -55.424M |
| Short Term Debt | 22.546M | 60.84M | 34.27M | 16.354M |
| Short Long Term Debt | - | - | - | - |
| Short Long Term Debt Total | 173.378M | - | - | - |
| Other Stockholder Equity | 890.915M | 338.566M | 127.179M | 79.991M |
| Property Plant Equipment | 254.342M | 112.195M | 80.934M | 80.19M |
| Total Current Assets | 294.568M | 327.98M | 359.933M | 91.684M |
| Long Term Investments | - | - | - | - |
| Short Term Investments | - | - | - | - |
| Net Receivables | 1.435M | 0.992M | 0.601M | 1.118M |
| Long Term Debt | - | - | - | - |
| Inventory | 68.848M | 57.095M | 38.468M | 28.437M |
| Accounts Payable | 20.791M | 30.89M | 40.788M | 37.306M |
| Accumulated Other Comprehensive Income | -0.647M | 0.016M | 0.109M | 0.022M |
| Non Currrent Assets Other | 8.497M | 0.471M | 0.284M | 0.282M |
| Non Current Assets Total | 274.139M | 112.666M | 84.818M | 84.172M |
| Capital Lease Obligations | 173.378M | - | - | - |
| Long Term Debt Total | - | - | - | - |
Cash Flow
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
|---|---|---|---|---|
| Investments | -60.181M | -48.513M | -20.07M | -32.632M |
| Total Cashflows From Investing Activities | -60.181M | -48.513M | -20.07M | -32.632M |
| Total Cash From Financing Activities | 3.291M | 22.999M | 245.936M | -83.362M |
| Net Income | -110.393M | -144.271M | -55.919M | 0M |
| Change In Cash | -47.831M | -57.669M | 258.661M | -94.363M |
| Begin Period Cash Flow | 256.416M | 314.085M | 55.424M | 149.787M |
| End Period Cash Flow | 208.585M | 256.416M | 314.085M | 55.424M |
| Total Cash From Operating Activities | 10.37M | -31.994M | 32.758M | 21.394M |
| Depreciation | 31.864M | 21.868M | 18.377M | 14.516M |
| Other Cashflows From Investing Activities | - | - | - | - |
| Dividends Paid | - | - | - | - |
| Change To Inventory | -11.794M | -18.624M | -10.02M | -12.61M |
| Sale Purchase Of Stock | 0M | -8.085M | 0M | -79.474M |
| Other Cashflows From Financing Activities | 0.547M | 31.084M | 276.836M | -3.888M |
| Capital Expenditures | 60.181M | 48.513M | 20.07M | 32.632M |
| Change In Working Capital | -14.55M | -24.496M | 25.387M | -1.621M |
| Other Non Cash Items | 5.417M | 7.757M | - | - |
| Free Cash Flow | -49.811M | -80.507M | 12.688M | -11.238M |
Funds
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | Fidelity® Series Blue Chip Growth | 1 year ago | 937179 |
| 2. | Fidelity® Small Cap Index | 1 year ago | 796539 |
| 3. | iShares Russell 2000 Growth ETF | 1 year ago | 748991 |
| 4. | Fidelity BlueChip Growth Commingled Pl A | 1 year ago | 716814 |
| 5. | Baillie Gifford Sustainable Growth | 1 year ago | 634523 |
| 6. | Baillie Gifford Sustainable Growth B Acc | 1 year ago | 631067 |
| 7. | T. Rowe Price Health Sciences | 1 year ago | 615911 |
| 8. | TIAA-CREF Quant Small-Cap Equity Instl | 1 year ago | 515420 |
| 9. | Fidelity® Blue Chip Growth | 1 year ago | 5561505 |
| 10. | Vanguard Total Stock Mkt Idx Inv | 1 year ago | 2577087 |
| 11. | T. Rowe Price Small-Cap Stock | 1 year ago | 2319324 |
| 12. | T. Rowe Price US Small-Cap Core Equity | 1 year ago | 2319324 |
| 13. | Vanguard Small Cap Index | 1 year ago | 2144870 |
| 14. | iShares Russell 2000 ETF | 1 year ago | 2017574 |
| 15. | Vanguard Small Cap Growth Index Inv | 1 year ago | 1206067 |
| 16. | T. Rowe Price U.S. SC Core Eq Tr-Z | 1 year ago | 1167944 |
| 17. | Fidelity® Blue Chip Growth K6 | 1 year ago | 1150436 |
| 18. | Vanguard Institutional Extnd Mkt Idx Tr | 1 year ago | 1079797 |
| 19. | T. Rowe Price Science & Tech | 1 year ago | 1068604 |
| 20. | T. Rowe Price Instl Small-Cap Stock | 1 year ago | 1061626 |
Institutions
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | D1 Capital Partners L.P. | 1 year ago | 14944023 |
| 2. | Durable Capital Partners LP | 1 year ago | 9641933 |
| 3. | FMR Inc | 1 year ago | 9277969 |
| 4. | Vanguard Group Inc | 1 year ago | 7850634 |
| 5. | BlackRock Inc | 1 year ago | 6948829 |
| 6. | Baillie Gifford & Co Limited. | 1 year ago | 6051671 |
| 7. | General Catalyst Group Management, LLC | 1 year ago | 5656571 |
| 8. | T. Rowe Price Investment Management,Inc. | 1 year ago | 5085053 |
| 9. | T. Rowe Price Associates, Inc. | 1 year ago | 2398570 |
| 10. | State Street Corporation | 1 year ago | 1973995 |
| 11. | Geode Capital Management, LLC | 1 year ago | 1602595 |
| 12. | Scopia Management Inc | 1 year ago | 1590744 |
| 13. | Rock Springs Capital Management LP | 1 year ago | 1575000 |
| 14. | Marshall Wace Asset Management Ltd | 1 year ago | 1508867 |
| 15. | Nuveen Asset Management, LLC | 1 year ago | 1084033 |
| 16. | Northern Trust Corp | 1 year ago | 756877 |
| 17. | Bank of New York Mellon Corp | 1 year ago | 743700 |
| 18. | Charles Schwab Investment Management Inc | 1 year ago | 598922 |
| 19. | Dimensional Fund Advisors, Inc. | 1 year ago | 570751 |
| 20. | Goldman Sachs Group Inc | 1 year ago | 554168 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).
Sponsored Articles
Loading...
Related Articles
Loading...